Of the 138 patients without bone metastases, positive expression of CXCR4 was detected in 43 of 113 (38.1%) HCC patients without metastases and in 14 of 25 (56.0%) HCC patients with distal metastases but without bone involvement. Here, CXCR4 is linked to hepatocellular carcinoma.